Provided in the present invention are highly stable D-configuration polypeptidesVAP andVAP having a high binding activity to the GRP78 protein, and also provided are an L-configuration polypeptideVAP and aVAP-orVAP-modified model drug and a macromolecule carrier material, and the use thereof in the construction of a tumour image and a drug-delivery system for targeted treatment.